Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
David A Fraser, Stephen A Harrison & Detlef Schuppan. (2022) Icosabutate: targeting metabolic and inflammatory pathways for the treatment of NASH. Expert Opinion on Investigational Drugs 31:12, pages 1269-1278.
Read now
Read now
Articles from other publishers (4)
Maxwell Duah, Kexin Zhang, Yiwen Liang, Vivian Adiila Ayarick, Kailin Xu & Bin Pan. (2023) Immune regulation of poly unsaturated fatty acids and free fatty acid receptor 4. The Journal of Nutritional Biochemistry 112, pages 109222.
Crossref
Crossref
Kazuo Nakamoto & Shogo Tokuyama. (2022) Docosahexaenoic Acid Attenuates the Progression of Nonalcoholic Steatohepatitis by Suppressing the Adipocyte Inflammation via the G Protein-Coupled Receptor 120/Free Fatty Acid Receptor 4 Pathway. Pharmacology 107:5-6, pages 330-338.
Crossref
Crossref
Gage M Stuttgen & Daisy Sahoo. (2021) FFAR4: A New Player in Cardiometabolic Disease?. Endocrinology 162:8.
Crossref
Crossref
Mengjiao Wu, Qingfei Li, Kangsen Mai & Qinghui Ai. (2021) Regulation of Free Fatty Acid Receptor 4 on Inflammatory Gene Induced by LPS in Large Yellow Croaker (Larimichthys crocea). Frontiers in Immunology 12.
Crossref
Crossref